SCHEMBL30987624

SCHEMBL30987624

COC(=O)c1ccc2c(c1)c(Br)nn2C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.44
▸ ALDH1A1 P00352 5/20 0.43
▸ HPGD P15428 4/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ GLA P06280 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ XDH P47989 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA14 Q9ULX7 1/20 0.42
▸ ELANE P08246 3/20 0.42
▸ NOTUM Q6P988 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20604896 1.00 MAPT (0.44) MAPTALDH1A1HPGDKDM4EGLA
SCHEMBL7426182 0.88 ALDH1A1 (0.43) MAPTALDH1A1HPGDKDM4EGLA
SCHEMBL29950049 0.88 ALDH1A1 (0.43) MAPTALDH1A1HPGDKDM4EGLA
SCHEMBL14869429 0.85 CA12 (0.47) MAPTALDH1A1HPGDKDM4EHSD17B10
SCHEMBL18561359 0.84 ADORA2A (0.47) MAPTALDH1A1HPGDKDM4EGLA
SCHEMBL14869360 0.83 HCAR3 (0.50) ALDH1A1HPGDKDM4E
SCHEMBL31173872 0.82 MAPT (0.50) MAPTALDH1A1HPGDKDM4EGLA
SCHEMBL14737303 0.82 MAPT (0.50) MAPTALDH1A1HPGDKDM4EGLA
SCHEMBL30987660 0.79 MAPT (0.42) MAPTALDH1A1HPGDKDM4EGLA
SCHEMBL30147699 0.79 MAPT (0.42) MAPTALDH1A1HPGDKDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676929-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 Dark Blue Therapeutics Ltd (GB) 2026-01-14 — — EP disclosed
EP-4638447-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS Dark Blue Therapeutics Ltd (GB) 2025-10-29 — — EP disclosed
WO-2024188906-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 DARK BLUE THERAPEUTICS LTD (GB) 2024-09-19 — — WO disclosed
WO-2024133560-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS DARK BLUE THERAPEUTICS LTD (GB) 2024-06-27 — — WO disclosed
Send feedback